down arrow

Tianjin Chase Sun Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000GF1
  • SHE: 300026
CNY
3.34
-0.01 (-0.3%)

Sep 22

SHE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Tianjin Chase Sun Pharmaceutical Co., Ltd.

Why is Tianjin Chase Sun Pharmaceutical Co., Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of -7.70% and Operating profit at -28.53% over the last 5 years
2
Flat results in Mar 26
  • OPERATING CASH FLOW(Y) Lowest at CNY 798.76 MM
  • INVENTORY TURNOVER RATIO(HY) Lowest at 1.14 times
  • DEBTORS TURNOVER RATIO(HY) Lowest at 1.69 times
3
With ROE of 0.80%, it has a fair valuation with a 0.98 Price to Book Value
  • Over the past year, while the stock has generated a return of -20.75%, its profits have risen by 125.3% ; the PEG ratio of the company is 1
  • At the current price, the company has a high dividend yield of 1
4
Below par performance in long term as well as near term
  • Along with generating -20.75% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Tianjin Chase Sun Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tianjin Chase Sun Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Tianjin Chase Sun Pharmaceutical Co., Ltd.
-10.93%
-0.32
23.94%
China Shanghai Composite
3.23%
1.20
14.07%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-7.70%
EBIT Growth (5y)
-28.53%
EBIT to Interest (avg)
8.11
Debt to EBITDA (avg)
0.21
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.58
Tax Ratio
64.97%
Dividend Payout Ratio
161.29%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.83%
ROE (avg)
5.79%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
116
Industry P/E
Price to Book Value
0.93
EV to EBIT
47.61
EV to EBITDA
16.64
EV to Capital Employed
0.92
EV to Sales
1.47
PEG Ratio
0.93
Dividend Yield
NA
ROCE (Latest)
1.93%
ROE (Latest)
0.80%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
NET PROFIT(HY)

Higher at CNY 78.09 MM

DEBT-EQUITY RATIO (HY)

Lowest at -14.68 %

RAW MATERIAL COST(Y)

Fallen by -10.61% (YoY

-14What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 785.89 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.23 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.56 times

NET SALES(Q)

At CNY 1,057.72 MM has Fallen at -9.57%

Here's what is working for Tianjin Chase Sun Pharmaceutical Co., Ltd.

Net Profit
Higher at CNY 78.09 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Debt-Equity Ratio
Lowest at -14.68 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -10.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tianjin Chase Sun Pharmaceutical Co., Ltd.

Operating Cash Flow
Lowest at CNY 785.89 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales
At CNY 1,057.72 MM has Fallen at -9.57%
over average net sales of the previous four periods of CNY 1,169.65 MM
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Inventory Turnover Ratio
Lowest at 1.23 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 1.56 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Footer loading